Kristian W. Pajtler

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 169 publications

Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

Journal: JCO precision oncology

Published: May 14, 2026

Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomas.

Journal: Nature

Published: May 06, 2026

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Journal: Genome medicine

Published: February 17, 2026

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 09, 2025

A brief history of ependymoma.

A brief history of ependymoma.

Journal: Neuro-oncology

Published: September 18, 2025

Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.

Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.

Journal: Scientific reports

Published: August 29, 2025

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.

Journal: Acta neuropathologica communications

Published: August 21, 2025

Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial.

Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial.

Journal: Neuro-oncology advances

Published: August 13, 2025

Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumors.

Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumors.

Journal: medRxiv : the preprint server for health sciences

Published: August 08, 2025

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Genomic analysis of PLNTY-like tumor progression into epithelioid glioblastoma: a case report.

Genomic analysis of PLNTY-like tumor progression into epithelioid glioblastoma: a case report.

Journal: Acta neuropathologica communications

Published: June 27, 2025

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries.

Journal: Neuro-oncology

Published: June 24, 2025

Showing 1-12 of 169

Last Updated: 09/26/2026